Intrinsiqq
Nuvectis Pharma Inc. logo

Nuvectis Pharma Inc. Quality Score

NVCT

Compare

Could not load quality data

This may be a temporary issue. If it persists, the ticker may not be covered yet.

SourceQuality score computed from the 10-Q filed 30 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 5 Nov 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Pharmaceutical Preparations · Pick stocks to compare with NVCT

CompareIntrinsic value
DSGNDesign Therapeutics, Inc.
$9.02-3.22%10
SMMTSummit Therapeutics Inc.
$10.46-1.09%10
MDGLMadrigal Pharmaceuticals, Inc.
$379.10-4.45%10
ARDXArdelyx Inc.
$2.99-2.29%40
AQSTAquestive Therapeutics Inc.
$3.46-6.61%10
PFEPfizer Inc.
$27.40-0.51%30
BMRNBiomarin Pharmaceutical Inc.
$60.41-1.64%45
EBSEmergent BioSolutions Inc.
$5.05-1.94%37

Held by ETFs

NVCT is in 5 US ETFs. The largest of them, with NVCT's weight in each:

Spot a number that looks wrong? Check it in NVCT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing NVCT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.